• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自随机前瞻性癌症筛查试验的无症状持续时间的非参数估计。

Nonparametric estimation of asymptomatic duration from a randomized prospective cancer screening trial.

作者信息

Shen Yu, Huang Xuelin

机构信息

Department of Biostatistics and Applied Mathematics, MD Anderson Cancer Center, University of Texas, Houston, 77030, USA.

出版信息

Biometrics. 2005 Dec;61(4):992-9. doi: 10.1111/j.1541-0420.2005.00363.x.

DOI:10.1111/j.1541-0420.2005.00363.x
PMID:16401272
Abstract

We propose a nonparametric estimation of preclinical duration distribution in cancer based on data from a randomized early detection trial. In cancer screening studies, the preclinical duration of a disease is of great interest for better understanding the natural history of the disease, and for developing optimal screening strategies. To estimate the sojourn time distribution nonparametrically, we first estimate the distribution of the age at onset of preclinical disease nonparametrically using data from the screening arm in a randomized screening trial, and the distribution for the age at onset of clinical disease from the control arm of the randomized screening trial. Finally, by using deconvolution the two estimated distributions lead to a nonparametric estimate of the distribution for the gap time between the onset of preclinical disease and the onset of clinical disease. We illustrate the methodology using data from a randomized breast cancer screening trial.

摘要

我们基于一项随机早期检测试验的数据,提出了一种用于癌症临床前病程分布的非参数估计方法。在癌症筛查研究中,疾病的临床前病程对于更好地理解疾病的自然史以及制定最佳筛查策略具有重要意义。为了非参数估计停留时间分布,我们首先使用随机筛查试验中筛查组的数据非参数估计临床前疾病发病年龄的分布,以及使用随机筛查试验对照组的数据估计临床疾病发病年龄的分布。最后,通过反卷积,这两个估计分布得出临床前疾病发病与临床疾病发病之间间隔时间分布的非参数估计。我们使用一项随机乳腺癌筛查试验的数据来说明该方法。

相似文献

1
Nonparametric estimation of asymptomatic duration from a randomized prospective cancer screening trial.来自随机前瞻性癌症筛查试验的无症状持续时间的非参数估计。
Biometrics. 2005 Dec;61(4):992-9. doi: 10.1111/j.1541-0420.2005.00363.x.
2
Alternative definitions of comparable case groups and estimates of lead time and benefit time in randomized cancer screening trials.随机癌症筛查试验中可比病例组的替代定义以及领先时间和受益时间的估计。
Stat Med. 2003 Jan 15;22(1):83-111. doi: 10.1002/sim.1331.
3
Estimation of age-specific sensitivity and sojourn time in breast cancer screening studies.乳腺癌筛查研究中年龄特异性敏感度和停留时间的估计。
Stat Med. 2005 Oct 30;24(20):3123-38. doi: 10.1002/sim.2178.
4
Significance tests for cancer screening trials.
Biometrics. 1989 Sep;45(3):883-90.
5
Effect of length biased sampling of unobserved sojourn times on the survival distribution when disease is screen detected.疾病通过筛查检测出时,未观察到的停留时间的长度偏倚抽样对生存分布的影响。
Stat Med. 2009 Jul 20;28(16):2116-46. doi: 10.1002/sim.3601.
6
[A study on scheduling periodic examinations for the early detection of breast cancer in Korea].[韩国乳腺癌早期检测定期检查的研究]
J Prev Med Public Health. 2006 Jul;39(4):346-52.
7
Estimating sample size for a randomized clinical trial of lung cancer screening.估算肺癌筛查随机临床试验的样本量。
Contemp Clin Trials. 2008 Jul;29(4):466-77. doi: 10.1016/j.cct.2007.10.007. Epub 2007 Nov 9.
8
Computational methods in medical decision making: to screen or not to screen?医学决策中的计算方法:筛查还是不筛查?
Stat Med. 2005 Feb 28;24(4):569-81. doi: 10.1002/sim.2037.
9
Robust modeling in screening studies: estimation of sensitivity and preclinical sojourn time distribution.筛查研究中的稳健建模:灵敏度估计与临床前停留时间分布
Biostatistics. 2005 Oct;6(4):604-14. doi: 10.1093/biostatistics/kxi030. Epub 2005 Apr 28.
10
Administrative and artificial censoring in censored regression models.删失回归模型中的管理性和人为删失
Stat Med. 2001 Aug 15;20(15):2287-304. doi: 10.1002/sim.850.

引用本文的文献

1
Does delaying curative surgery for colorectal cancer influence long-term disease-free survival? A cohort study.结直肠癌患者延迟根治性手术是否会影响无病生存期的长期预后?一项队列研究。
Langenbecks Arch Surg. 2021 Nov;406(7):2383-2390. doi: 10.1007/s00423-021-02251-4. Epub 2021 Jul 11.
2
Recognizing the Limitations of Cancer Overdiagnosis Studies: A First Step Towards Overcoming Them.认识癌症过度诊断研究的局限性:克服这些局限性的第一步。
J Natl Cancer Inst. 2015 Nov 18;108(3). doi: 10.1093/jnci/djv345. Print 2016 Mar.
3
Calibration methods used in cancer simulation models and suggested reporting guidelines.
癌症模拟模型中使用的校准方法及建议的报告指南。
Pharmacoeconomics. 2009;27(7):533-45. doi: 10.2165/11314830-000000000-00000.